MIRA PHARMACEUTICALS INC (MIRA) Stock Analyst Earnings Estimates
NASDAQ:MIRA - Nasdaq - US60458C1045 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | ||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A -9.81% | N/A 6,240.78% | |
| EBIT YoY % growth | -67.6K | -2.152M -3,083.73% | -7.048M -227.47% | -8.526M -20.97% | -8.018M 5.96% | N/A -12.57% | N/A 6,225.87% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -0.53 23.59% | N/A 25.91% | N/A 15.58% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.09 42.20% | -0.09 42.20% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.11 8.33% | -0.15 | 0.04 | 25.63% |
| Q4 2024 Q2Q % growth | -0.15 36.06% | -0.24 | 0.09 | 37.42% |
| Q3 2024 Q2Q % growth | -0.15 42.31% | -0.16 | 0.01 | 5.12% |
| Q2 2024 Q2Q % growth | -0.11 | -0.10 | -0.01 | -7.84% |
| Q1 2024 Q2Q % growth | -0.12 | -0.10 | -0.02 | -17.65% |
| Q3 2023 Q2Q % growth | -0.26 | -0.08 | -0.18 | -218.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -4% | 0% | 28.7% |
| Revenue | N/A | N/A | N/A | N/A |